<DOC>
	<DOCNO>NCT01990105</DOCNO>
	<brief_summary>FINFIB 2 observational investigator-driven study seek examine current treatment practice atrial fibrillation Finland . The investigator hypothesis treatment atrial fibrillation improve since introduction new antiarrhythmic drug anticoagulant .</brief_summary>
	<brief_title>Treatment Atrial Fibrillation Finland</brief_title>
	<detailed_description>FINFIB 2 observational investigator-driven study seek examine current treatment practice atrial fibrillation ( AF ) Finland . It produce important information whether introduction new agent take place accordance treatment guideline different part Finland . Working hypothesis treatment AF improve since introduction new antiarrhythmic drug anticoagulant . However , investigator also expect find geographical difference use agent . The expect outcome investigator identify difference able good homogenize treatment AF different part country different level health care system . The study data obtain form cross-section sample two week . All patient ECG-diagnosed AF attend emergency clinic examination treatment arrhythmia cardiac disease study period include . The investigator estimate number patient 1000 . Aside background information , risk data ( e.g . CHA2DS2VASc ) , symptom ( EHRA classification ) , medication , examination choice treatment , data record patient AF date birth gender . The patient divide four group accord type AF : 1 . New onset AF , 2 . Paroxysmal AF , 3 . Persistent AF , 4 . Permanent AF . The data obtain local study doctor use online , protect data collection program . The data store secure server , access data entry investigator study center . The database personal data register , identity code store point individual patient identify later database . Only investigator group right use database .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>All adult patient ECGdiagnosed AF attend emergency clinic examination treatment arrhythmia cardiac disease study period include .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>atrial fibrillation</keyword>
	<keyword>anticoagulation</keyword>
	<keyword>antiarrhythmic medication</keyword>
	<keyword>CHA2DS2VASc score</keyword>
	<keyword>HAS-BLED score</keyword>
	<keyword>CHADS2 score</keyword>
</DOC>